SCHEMBL7020232

SCHEMBL7020232

COC(=O)c1cc2nc[nH]c2cc1C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.45
TDP1 Q9NUW8 2/20 0.45
QPCT Q16769 2/20 0.45
MMP12 P39900 1/20 0.45
HDAC6 Q9UBN7 1/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
ABL1 P00519 2/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 1/20 0.43
APEX1 P27695 1/20 0.43
RECQL P46063 1/20 0.43
BLM P54132 1/20 0.43
SRC P12931 1/20 0.43
ATM Q13315 1/20 0.41
POLB P06746 1/20 0.40
HSD11B1 P28845 1/20 0.40
MAP2K1 Q02750 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22533358 0.87 QPCT (0.50) KMT2ATDP1QPCTMMP12RAB9A
SCHEMBL25727792 0.87 HDAC6 (0.43) KMT2ATDP1QPCTMMP12HDAC6
SCHEMBL24501453 0.87 HDAC6 (0.43) KMT2ATDP1QPCTMMP12HDAC6
SCHEMBL8802475 0.87 KDM4E (0.54) KMT2ATDP1QPCTMMP12HDAC6
SCHEMBL8802469 0.87 KDM4E (0.54) KMT2ATDP1QPCTMMP12HDAC6
SCHEMBL23625906 0.85 KMT2A (0.46) KMT2ATDP1QPCTMMP12HDAC6
SCHEMBL30952908 0.82 CYP3A4 (0.46) KMT2ATDP1QPCTMMP12HDAC6
SCHEMBL25387349 0.82 CYP3A4 (0.46) KMT2ATDP1QPCTMMP12HDAC6
SCHEMBL7020295 0.80 KDM4E (0.41) KMT2ATDP1QPCTMMP12HDAC6
SCHEMBL5139687 0.79 MAPT (0.52) KMT2AQPCTRAB9ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
WO-2003051898-A1 UNUSUAL NUCLEOSIDE LIBRARIES, COMPOUNDS, AND PREFERRED USES AS ANTIVIRAL AND ANTICANCER AGENTS RIBAPHARM INC. (US) 2003-06-26 WO disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed